Treatment of high-risk PE and the role of catheter-directed therapies

O. Sanchez

Source: ERS Course 2019 - Masterclass in pulmonary embolism
Number: 4

WebcastPDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Sanchez. Treatment of high-risk PE and the role of catheter-directed therapies. ERS Course 2019 - Masterclass in pulmonary embolism

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Management of recurrent PE in patients on anticoagulant therapy
Source: Virtual Congress 2021 – Pulmonary embolism: special situations
Year: 2021

Management of anticoagulant and antiplatelet therapy in patients undergoing interventional pulmonary procedures
Source: Eur Respir Rev, 26 (145) 170020; 10.1183/16000617.0020-2017
Year: 2017

Treatment of CTEPH and anticoagulation of choice
Source: ERS Course 2019 - Masterclass in pulmonary embolism
Year: 2019

Prospects for the prevention and treatment of venous thromboembolism
Source: ISSN=1025-448x, ISBN=1-904097-31-6, page=155
Year: 2004

Effectiveness of thrombolytic therapy in pulmonary thromboembolism
Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology
Year: 2007

Advanced therapies for life-threatening PE: low-dose systemic thrombolysis, catheter-directed thrombolysis and extracorporeal membrane oxygenation (ECMO)
Source: International Congress 2018 – Pulmonary embolism: what we need to know
Year: 2018

Interventional treatment of pulmonary embolism: catheter-delivered local thrombolysis versus reduced-dose systemic thrombolysis
Source: Virtual Congress 2021 – Pulmonary embolism: controversies in management
Year: 2021

Improved identification of thrombolysis candidates amongst intermediate-risk pulmonary embolism patients: implications for future trials
Source: Eur Respir J, 51 (1) 1701775; 10.1183/13993003.01775-2017
Year: 2018

Successful use of thrombolytic therapy in the management of acute proximal pulmonary embolism without significant haemodynamic compromise
Source: Eur Respir J 2005; 26: Suppl. 49, 272s
Year: 2005

Comparision of side effects between thrombolytic and anticoagulation therapy in patients with Pulmonary Embolism
Source: Virtual Congress 2020 – Pulmonary embolism
Year: 2020

Management of antithrombotic agents in patients undergoing flexible bronchoscopy
Source: Eur Respir Rev, 26 (145) 170001; 10.1183/16000617.0001-2017
Year: 2017

Long-term riociguat treatment towards implementing a targeted treatment strategy in patients with idiopathic pulmonary arterial hypertension
Source: Virtual Congress 2020 – Epidemiology and treatment of pulmonary arterial hypertension
Year: 2020

Direct oral anticoagulant therapy in patients with morbid obesity after intermediate- or high-risk pulmonary emboli
Source: ERJ Open Res, 7 (1) 00554-2020; 10.1183/23120541.00554-2020
Year: 2021

Efficacy and safety of systemic and prolonged low-dose thrombolysis in thromboembolic disease
Source: Eur Respir J 2002; 20: Suppl. 38, 478s
Year: 2002

The role of combination therapy in managing pulmonary arterial hypertension
Source: Eur Respir Rev 2014; 23: 469-475
Year: 2014

Anticoagulant treatment for acute pulmonary embolism: a pathophysiology-based clinical approach
Source: Eur Respir J 2015; 45: 1142-1149
Year: 2015

Successful pregnancy outcome in patients with pulmonary arterial hypertension receiving prostayclin therapy
Source: Annual Congress 2004 - Pulmonary hypertension
Year: 2004

Combination of prognostic tools for identifying high-risk normotensive patients with acute symptomatic pulmonary embolism
Source: Annual Congress 2010 - Pulmonary embolism
Year: 2010

Should thrombolysis and sildenafil be given in the acute management of patients with large pulmonary embolism? An assessment of the short and long-term outcomes.
Source: International Congress 2019 – Pulmonary embolism: from diagnosis to prognosis and treatment
Year: 2019